Amneal Pharmaceuticals, Inc.

Q3 2024 13F Holders

Symbol
AMRX
CUSIP
03168L105
Type
Equity
Class
COM STK CL A
Num filings
190
Total reported value, excl. options
$1.20 B
Manager Report Date Value ($000) Shares Option Type